English
中文简体
中文繁体
Company
Overview
Board of Directors
Partnering
Core competence
Technology
Bispecific
Mix-mAb
Biologics Manufacturing
Publications
Pipeline
Overview
Envafolimab(KN035)
KN046
KN026
KN026+KN046
KN019
KN052
JSKN003
Investors
Information Disclosure
Corporate Governance
Stock Information
IR Contacts
Email Subscription
News
Press Release
Media Report
Career
Corporate Culture
Job Opportunities
Contact Us
Company
Overview
Board of Directors
Partnering
Core competence
Technology
Bispecific
Mix-mAb
Biologics Manufacturing
Publications
Pipeline
Overview
Envafolimab(KN035)
KN046
KN026
KN026+KN046
KN019
KN052
JSKN003
Investors
Information Disclosure
Corporate Governance
Stock Information
IR Contacts
Email Subscription
News
Press Release
Media Report
Career
Corporate Culture
Job Opportunities
Contact Us
English
中文简体
中文繁体
Investors
Information Disclosure
Listing Documents
Financial Reports
Announcements & Circulars
Company Presentation
Corporate Governance
Stock Information
IR Contacts
Email Subscription
Stock Information
Alphamab Oncology
15.400
(
0.40%
)
Highest
15.760
Lowest
14.820
Buying Price
15.400
Selling Price
15.400
Volume
464.1
Date And Time：
2023/05/05 16:08:30
Hong Kong time,offers a delay of fifteen minutes
